Apse's Grant

Apse raised a round of funding on December 05, 2016. Investors include National Science Foundation.

Apse is a biotechnology company seeking to commercialize a portfolio of Novel Nanomaterials useful for the manufacture of recombinant RNA and proteins and for Nanotechnology applications.…

Articles about Apse's Grant: